<?xml version="1.0" encoding="UTF-8"?>
<ref id="R54">
 <label>54.</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Doench</surname>
   <given-names>JG</given-names>
  </name>, 
  <name>
   <surname>Fusi</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>Sullender</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Hegde</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Vaimberg</surname>
   <given-names>EW</given-names>
  </name>, 
  <name>
   <surname>Donovan</surname>
   <given-names>KF</given-names>
  </name>, 
  <name>
   <surname>Smith</surname>
   <given-names>I</given-names>
  </name>, 
  <name>
   <surname>Tothova</surname>
   <given-names>Z</given-names>
  </name>, 
  <name>
   <surname>Wilen</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Orchard</surname>
   <given-names>R</given-names>
  </name>
  <etal/>: 
  <article-title>Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9</article-title>. 
  <source>Nat Biotechnol</source>
  <year>2016</year>, 
  <volume>34</volume>:
  <fpage>184</fpage>â€“
  <lpage>191</lpage>.
  <pub-id pub-id-type="pmid">26780180</pub-id>
 </mixed-citation>
</ref>
